Patent Assignment
Reel/Frame 032157/0160
Assignment of Assignor's Interest
Recorded: 2014-02-06
Pages: 3
Assignor
BHALLA, KAPIL N
Executed: 2013-01-07
Assignee
THE UNIVERSITY OF KANSAS MEDICAL CENTER
3901 RAINBOW BOULEVARD, MAIL STOP 1039, KANSAS CITY, KANSAS, 66160
Covered Property
(1)
Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia.
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 6, 2014
From: HORRIGAN, STEPHEN
To: BETA CAT PHARMACEUTICALS LLC
Reel/Frame 032156/0942 →
Assignment of Assignor's Interest
Feb 6, 2014
From: THE UNIVERSITY OF KANSAS
To: BETA CAT PHARMACEUTICALS LLC
Reel/Frame 032157/0289 →
Assignment of Assignor's Interest
Mar 27, 2014
From: BHALLA, KAPIL N
To: THE UNIVERSITY OF KANSAS
Reel/Frame 032537/0674 →
Corrective Assignment to Correct the Nature of Conveyance to Read a Corrected Assignment to Correct the Assignee's Name on Reel Number 032157/0160 Previously Recorded on Reel 032537 Frame 0674. Assignor(S) Hereby Confirms the Corrected Assignment.
Jun 19, 2014
From: BHALLA, KAPIL N
To: THE UNIVERSITY OF KANSAS; THE UNIVERSITY OF KANSAS
Reel/Frame 033203/0434 →
Assignment of Assignor's Interest
Apr 21, 2015
From: BETA CAT PHARMACEUTICALS, LLC
To: BETA CAT PHARMACEUTICALS, INC.
Reel/Frame 035462/0486 →
Change of Name
Jul 31, 2024
From: BETA CAT PHARMACEUTICALS, INC.
To: ITERION THERAPEUTICS, INC.
Reel/Frame 068235/0827 →